Orthopedic Surgery FAQs
Operational answers covering Medicare, prior authorization, site of service, delegated vendors, documentation, coding, quality, artificial intelligence, and performance.
These frequently asked questions provide operational guidance for orthopedic practices, ambulatory surgery centers, hospital outpatient departments, prior authorization teams, utilization management staff, coders, revenue cycle leaders, and executives. Payer-specific requirements must be verified before reliance.
Frequently Asked Questions
The answers below are operational guidance as of the publication date and are not coverage determinations. Verify every payer-specific position against the applicable current policy before relying on it.
Does Medicare require prior authorization for orthopedic surgery?
Not generally, and not nationally. Original Medicare has historically adjudicated orthopedic coverage at the claim rather than in advance. The exception is the WISeR Model, which applies prior authorization or pre-payment review to selected service categories for Original Medicare beneficiaries in Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington. Arthroscopic lavage and arthroscopic debridement for the osteoarthritic knee and cervical fusion are among the included categories. Medicare Advantage plans, by contrast, apply prior authorization extensively.
What is the WISeR Model and does it change coverage rules?
It is a CMS Innovation Center payment model testing technology-assisted prior authorization and pre-payment review in Original Medicare. CMS has stated that it does not change Medicare benefit, coverage, coding, or payment rules and that determinations are made against the relevant National and Local Coverage Determinations and the standard documentation requirements. What it changes is timing: the review happens before the service rather than after the claim.
What happens if a WISeR-included service is performed without a unique tracking number?
For hospital outpatient department and ambulatory surgery center claims, the unique tracking number must appear on the facility claim when prior authorization was obtained. Absent the number, claims for included services are suspended for medical review. Associated services and items, including anesthesia, implanted devices, physician services, and facility fees, follow the determination on the primary service.
Why did the Inpatient Only list phase-out increase our denial risk?
Because the designation functioned as a protective payment rule. While a procedure was on the list, Medicare would not pay for it in an outpatient setting, so the site-of-service argument did not exist. Once removed, inpatient status must be independently justified and is exposed to medical review, and commercial and Medicare Advantage payers can be expected to press for the lower-cost setting.
If a procedure was added to the ASC covered procedures list, can we schedule it?
Only after three separate confirmations. First, that the procedure is on the current calendar year list, verified against the CMS addenda. Second, that the specific payer's contract recognizes the procedure in the ambulatory surgery center place of service, since a commercial payer is not bound by the Medicare list. Third, that the case clears contribution margin after implant and device cost.
Which vendor reviews our orthopedic authorizations?
That depends on the payer, the product line, and often the service family within the same payer. eviCore by Evernorth and Carelon Medical Benefits Management carry the majority of delegated musculoskeletal surgical volume; Cohere Health, Evolent, and TurningPoint appear in specific arrangements. Maintain a payer-product-service-family matrix and refresh it quarterly and at every contract renewal.
Where do we find the criteria a vendor will apply?
Both major vendors publish their guidelines. Carelon posts dated musculoskeletal guidelines with an archive of superseded versions and a preview of upcoming changes. eviCore posts its Comprehensive Musculoskeletal Management guidelines by number and provides a pathway to request the specific criteria applied to an individual determination. Always confirm you are reading the version applicable to that member's plan, because plan-specific versions are maintained in parallel.
How long should conservative therapy last before surgery is authorized?
There is no single answer, and this is exactly the question where practices lose time. The required duration, the acceptable modalities, and the look-back window vary by payer, by vendor guideline, and by joint. The operational answer is to document every modality with start date, end date, frequency, and outcome, so that whatever threshold applies, the evidence exists to demonstrate it.
Our therapy was delivered somewhere else. Is our attestation enough?
Usually not. Reviewers generally expect source documentation rather than a second-hand summary. Build external record acquisition into intake rather than into the authorization step, because requesting records at the point of authorization adds days to a process already under time pressure.
What is the most common reason orthopedic authorizations are non-affirmed?
Insufficient documentation of failed conservative therapy, followed by imaging that is attached but not interpreted by the surgeon in terms that support the specific procedure requested. Both are documentation defects rather than clinical ones.
Can we require the payer to tell us which criterion was unmet?
For impacted payers, operational provisions effective January 1, 2026 require a specific reason for a denied prior authorization for non-drug services regardless of how the request was submitted. Beyond that, state utilization review statutes frequently require criteria transparency. Ask for the guideline name, number, and version and the specific unmet criterion as a standing element of every appeal.
How fast must a payer decide?
For impacted payers under the CMS Interoperability and Prior Authorization final rule, expedited decisions are due within 72 hours and standard decisions within 7 calendar days, effective January 1, 2026. State law may impose shorter timelines for state-regulated products. Know both, and cite the shorter one.
Should we accept a peer-to-peer review?
Yes, when it is offered and the case is defensible, but treat it as a narrow clinical conversation about a specific unmet criterion rather than as a second submission. Prepare a one-page brief for the surgeon identifying the criterion and the responsive chart evidence with dates. Then work on reducing peer-to-peer volume, because a high rate signals preventable documentation gaps.
Is TEAM relevant to us if we are a physician group rather than a hospital?
Directly, no: the Transforming Episode Accountability Model holds participant acute care hospitals at risk. Practically, yes: surgeon decisions drive episode cost and quality, participant hospitals will seek alignment, and financial arrangements between participants and physician groups are contemplated. Understand the target price mechanics and the post-acute levers before negotiating.
What is the Ambulatory Specialty Model and does it apply to orthopedic surgeons?
It is a mandatory, two-sided-risk model with five performance years beginning January 1, 2027, focused on heart failure and low back pain. Orthopedic surgery is a named specialty in the low back pain cohort along with anesthesiology, interventional pain management, pain management, neurosurgery, and physical medicine and rehabilitation. Inclusion depends on geography, specialty designation, and an episode volume threshold, and there is no opt-out for clinicians who meet the criteria.
Which MIPS Value Pathway applies to orthopedic surgery?
Improving Care for Lower Extremity Joint Repair is the pathway designed for orthopedic surgery, with cost measures tied to elective primary hip and knee arthroplasty. A separate musculoskeletal rehabilitation pathway serves physical and occupational therapy. Multispecialty groups electing MVP reporting must form subgroups beginning with the 2026 performance year, and MVP reporting requires registration within the annual window.
Why are there two Medicare physician conversion factors in 2026?
Statute requires differential updates beginning in CY 2026 for qualifying alternative payment model participants and for clinicians who are not qualifying participants. CMS finalized $33.5675 and $33.4009 respectively. Practices should know which of their clinicians hold qualifying participant status.
What is the efficiency adjustment and how does it affect orthopedics?
CMS finalized a 2.5 percent reduction to work relative value units and the corresponding intraservice physician time for most non-time-based services, excluding time-based codes. Procedural specialties absorb this more heavily than evaluation and management-weighted specialties. Model it against your actual case mix rather than a specialty-average impact table.
What changed in CPT 2026 for orthopedics?
Core arthroplasty, arthroscopy, fracture care, and evaluation and management families were largely stable. Targeted changes include an editorial revision affecting sacroiliac joint arthrodesis reporting, two limb-lengthening reconstruction codes, an add-on code for annular defect repair with a bone-anchored closure device, and a code for percutaneous balloon decompression of the median nerve. Verify every descriptor against the AMA CPT 2026 professional edition before use.
Does a new CPT code mean the service is covered?
No. A code is a reporting mechanism, not a coverage determination. Category III codes in particular are frequently non-covered. Screen every new code against the specific payer's policy before the service is offered to patients.
Can a payer deny our request using artificial intelligence?
The answer is increasingly jurisdiction-specific. A growing number of states now require that an adverse medical necessity determination be made by a licensed physician or other qualified health professional and prohibit artificial intelligence from serving as the sole basis to deny, delay, or modify a service. Several also impose disclosure, individualized-review, certification, and audit requirements. Verify the statute and effective date for each state in which you operate, and ask on the record whether an automated tool contributed to the determination and at which step.
Can we use AI to write our notes and pick our codes?
AI is appropriate for drafting, structuring, summarizing, and checking completeness, under a governance framework with a named accountable human reviewer. It is not appropriate as the authority for a code, a descriptor, a coverage position, or a policy effective date. Those come from the primary source. GoHealthcare's experience across this Library is that fabricated codes and obsolete descriptors enter work product through exactly this shortcut.
What single metric best predicts orthopedic financial performance?
First-pass approval rate on prior authorization. It is a direct proxy for documentation quality and criteria fluency, it predicts denial volume better than any downstream metric, and it drives the surgeon confidence that keeps cases inside the process rather than around it.
How often should we refresh our payer and vendor reference?
Quarterly at minimum, and at every contract renewal or delegation change. Vendor guidelines are revised on their own schedules, plan-specific versions exist in parallel, and at least one vendor expressly reserves the right to change guidelines without prior notice.
What is the single highest-return operational change for most orthopedic practices?
The weekly pre-surgical huddle reconciling every case scheduled in the next two weeks against the authorization record, combined with a scheduling rule that no case is confirmed without an active, matching authorization. It prevents the most expensive failure in the specialty, which is an unauthorized case that has already consumed operating room time and implant cost.
Authoritative References
Coverage policies, code sets, model parameters, and utilization management criteria change. Verify currency at the time of use.
- CMS Medicare Coverage Database: https://www.cms.gov/medicare-coverage-database
- CMS WISeR Model: https://www.cms.gov/priorities/innovation/innovation-models/wiser
- CMS Interoperability and Prior Authorization Final Rule: https://www.cms.gov/newsroom/fact-sheets/cms-interoperability-prior-authorization-final-rule-cms-0057-f
- Carelon Current Musculoskeletal Guidelines: https://guidelines.carelonmedicalbenefitsmanagement.com/current-musculoskeletal-guidelines/
- eviCore Clinical Guidelines: https://www.evicore.com/provider/clinical-guidelines
- CMS Hospital Outpatient and ASC Payment System: https://www.cms.gov/medicare/payment/prospective-payment-systems/hospital-outpatient
- CMS Transforming Episode Accountability Model: https://www.cms.gov/priorities/innovation/innovation-models/team-model
- CMS Ambulatory Specialty Model: https://www.cms.gov/priorities/innovation/innovation-models/asm
- CMS Quality Payment Program: https://qpp.cms.gov
- American Medical Association CPT Resources: https://www.ama-assn.org/practice-management/cpt
Related Orthopedic Pages
Orthopedic Surgery Specialty Guide
Executive entry point for orthopedic service-line operations and the complete Orthopedic Surgery Specialty Hub.
Open this page →Orthopedic Prior Authorization
Decision pathways, payer criteria, authorization workflow, peer-to-peer, and appeals.
Open this page →Orthopedic Procedure Library
Procedure categories and links across the GoHealthcare MSK Specialty Procedure Library.
Open this page →Strengthen Orthopedic Operations
GoHealthcare Practice Solutions supports orthopedic and musculoskeletal organizations with prior authorization, medical necessity, payer intelligence, documentation improvement, revenue cycle performance, compliance, and workflow design.
Request Help